Ventas, Inc. (NYSE:VTR) Short Interest Up 56.6% in June

Ventas, Inc. (NYSE:VTR) saw a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 6,941,700 shares, an increase of 56.6% from the May 30th total of 4,432,400 shares. Approximately 2.0% of the shares of the company are short sold. Based on an average trading volume of 2,330,000 shares, the days-to-cover ratio is presently 3.0 days.

Shares of Ventas stock traded down $0.32 on Friday, hitting $69.12. The company’s stock had a trading volume of 2,049,358 shares, compared to its average volume of 2,908,066. The company has a quick ratio of 0.56, a current ratio of 0.56 and a debt-to-equity ratio of 1.05. Ventas has a 1 year low of $51.80 and a 1 year high of $73.74. The firm’s fifty day moving average is $67.34. The firm has a market cap of $24.89 billion, a P/E ratio of 16.98, a price-to-earnings-growth ratio of 4.53 and a beta of 0.28.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Friday, April 26th. The real estate investment trust reported $0.99 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.96 by $0.03. Ventas had a return on equity of 4.04% and a net margin of 12.19%. The firm had revenue of $942.80 million during the quarter, compared to analyst estimates of $908.61 million. During the same quarter in the previous year, the business earned $0.22 EPS. Ventas’s revenue for the quarter was down .1% compared to the same quarter last year. As a group, equities analysts forecast that Ventas will post 3.83 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Monday, July 1st were issued a $0.7925 dividend. This represents a $3.17 annualized dividend and a yield of 4.59%. The ex-dividend date was Friday, June 28th. Ventas’s payout ratio is 77.89%.

A number of research firms have weighed in on VTR. Mitsubishi UFJ Financial Group lifted their price objective on Ventas to $67.00 and gave the company a “neutral” rating in a research note on Wednesday, June 19th. ValuEngine upgraded Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, May 17th. Morgan Stanley set a $111.00 price objective on Procter & Gamble and gave the company a “buy” rating in a research note on Thursday, March 28th. Raymond James set a C$13.50 price objective on Secure Energy Services and gave the company a “strong-buy” rating in a research note on Tuesday, April 30th. Finally, BMO Capital Markets reiterated a “market perform” rating and set a $73.00 price objective on shares of Ventas in a research note on Wednesday, June 19th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company’s stock. Ventas currently has a consensus rating of “Hold” and an average price target of $64.82.

In other Ventas news, EVP T Richard Riney sold 29,702 shares of Ventas stock in a transaction dated Thursday, June 20th. The stock was sold at an average price of $70.45, for a total transaction of $2,092,505.90. Following the completion of the transaction, the executive vice president now owns 163,488 shares in the company, valued at approximately $11,517,729.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Debra A. Cafaro sold 68,084 shares of Ventas stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $66.54, for a total value of $4,530,309.36. Following the transaction, the chairman now owns 805,835 shares of the company’s stock, valued at approximately $53,620,260.90. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 165,866 shares of company stock valued at $11,323,058. 1.40% of the stock is currently owned by insiders.

A number of hedge funds have recently bought and sold shares of VTR. Comerica Securities Inc. raised its position in shares of Ventas by 56.3% during the fourth quarter. Comerica Securities Inc. now owns 6,942 shares of the real estate investment trust’s stock worth $412,000 after purchasing an additional 2,500 shares during the period. Raymond James Financial Services Advisors Inc. raised its position in shares of Ventas by 13.2% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 40,639 shares of the real estate investment trust’s stock worth $2,381,000 after purchasing an additional 4,738 shares during the period. Bessemer Group Inc. raised its position in shares of Ventas by 481.1% during the fourth quarter. Bessemer Group Inc. now owns 4,161 shares of the real estate investment trust’s stock worth $243,000 after purchasing an additional 3,445 shares during the period. Berman Capital Advisors LLC acquired a new position in shares of Ventas during the fourth quarter worth approximately $41,000. Finally, Natixis Advisors L.P. raised its position in shares of Ventas by 29.6% during the fourth quarter. Natixis Advisors L.P. now owns 24,273 shares of the real estate investment trust’s stock worth $1,422,000 after purchasing an additional 5,540 shares during the period. Institutional investors own 87.08% of the company’s stock.

About Ventas

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.

Featured Story: Price to Earnings Ratio (PE) Basics

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.